Shoshana M Rosenberg1,2, Ines Vaz-Luis3, Jingyi Gong4, Padma Sheila Rajagopal5, Kathryn J Ruddy6, Rulla M Tamimi4,7, Lidia Schapira8, Steven Come4,9, Virginia Borges10, Janet S de Moor11, Ann H Partridge12,4. 1. Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. shoshana_rosenberg@dfci.harvard.edu. 2. Harvard Medical School, Boston, MA, USA. shoshana_rosenberg@dfci.harvard.edu. 3. Gustave Roussy Cancer Institute, Paris, France. 4. Harvard Medical School, Boston, MA, USA. 5. Section of Hematology/Oncology, The University of Chicago, Chicago, IL, USA. 6. Mayo Clinic, Rochester, MN, USA. 7. Brigham and Women's Hospital, Boston, MA, USA. 8. Stanford University Medical Center, Stanford, CA, USA. 9. Beth Israel Deaconess Medical Center, Boston, MA, USA. 10. University of Colorado Cancer Center, Aurora, CO, USA. 11. Division of Cancer Control and Population Sciences, National Cancer Institute, Rockville, MD, USA. 12. Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.
Abstract
PURPOSE: Little is known about how a breast cancer diagnosis and treatment affects job-related outcomes in young women with breast cancer, who are an integral part of the workforce. We sought to describe employment trends among young breast cancer survivors. METHODS: 911 women with non-metastatic breast cancer were surveyed about employment-related outcomes 1 year post-diagnosis. Participants were enrolled in the Young Women's Breast Cancer Study an ongoing, multi-center cohort of women diagnosed with breast cancer at age ≤ 40. RESULTS: Among 911 women, median age at diagnosis was 36 years (range 17-40). Most women (80%, n = 729) were employed 1 year post-diagnosis. Among the 7% (n = 62) employed before diagnosis but who reported unemployment at 1 year, approximately half reported they were unemployed for health reasons. Among employed women, 7% said treatment affected their ability to perform their job. Women with stage-three disease (vs. stage 1 disease, odds ratio (OR): 3.73, 95% CI 1.39-9.97) and those who reported having money to pay bills after cutting back or difficulty paying bills at baseline (vs. having enough money for special things, OR 2.70, 95% CI 1.32-5.52) at baseline were more likely to have transitioned out of the workforce. CONCLUSIONS: Our results suggest an impact of disease burden and socioeconomic status on employment in young breast cancer survivors. There is a need to ensure young survivors who leave the workforce following diagnosis are sufficiently supported given the potential adverse psychosocial and financial impacts of unemployment on survivors, their families, communities, and society.
PURPOSE: Little is known about how a breast cancer diagnosis and treatment affects job-related outcomes in young women with breast cancer, who are an integral part of the workforce. We sought to describe employment trends among young breast cancer survivors. METHODS: 911 women with non-metastatic breast cancer were surveyed about employment-related outcomes 1 year post-diagnosis. Participants were enrolled in the Young Women's Breast Cancer Study an ongoing, multi-center cohort of women diagnosed with breast cancer at age ≤ 40. RESULTS: Among 911 women, median age at diagnosis was 36 years (range 17-40). Most women (80%, n = 729) were employed 1 year post-diagnosis. Among the 7% (n = 62) employed before diagnosis but who reported unemployment at 1 year, approximately half reported they were unemployed for health reasons. Among employed women, 7% said treatment affected their ability to perform their job. Women with stage-three disease (vs. stage 1 disease, odds ratio (OR): 3.73, 95% CI 1.39-9.97) and those who reported having money to pay bills after cutting back or difficulty paying bills at baseline (vs. having enough money for special things, OR 2.70, 95% CI 1.32-5.52) at baseline were more likely to have transitioned out of the workforce. CONCLUSIONS: Our results suggest an impact of disease burden and socioeconomic status on employment in young breast cancer survivors. There is a need to ensure young survivors who leave the workforce following diagnosis are sufficiently supported given the potential adverse psychosocial and financial impacts of unemployment on survivors, their families, communities, and society.
Entities:
Keywords:
Breast cancer; Employment; Outcomes; Survivorship
Authors: P van Muijen; N L E C Weevers; I A K Snels; S F A Duijts; D J Bruinvels; A J M Schellart; A J van der Beek Journal: Eur J Cancer Care (Engl) Date: 2012-12-26 Impact factor: 2.520
Authors: Jennifer M Gierisch; Jo Anne Earp; Noel T Brewer; Barbara K Rimer Journal: Cancer Epidemiol Biomarkers Prev Date: 2010-03-30 Impact factor: 4.254
Authors: Charlotte Peugniez; Sophie Fantoni; Ariane Leroyer; Joanna Skrzypczak; Marie Duprey; Jacques Bonneterre Journal: Bull Cancer Date: 2011-07 Impact factor: 1.276
Authors: Janet S de Moor; Angela B Mariotto; Carla Parry; Catherine M Alfano; Lynne Padgett; Erin E Kent; Laura Forsythe; Steve Scoppa; Mark Hachey; Julia H Rowland Journal: Cancer Epidemiol Biomarkers Prev Date: 2013-03-27 Impact factor: 4.254
Authors: M-L Lindbohm; E Kuosma; T Taskila; P Hietanen; K Carlsen; S Gudbergsson; H Gunnarsdottir Journal: Psychooncology Date: 2013-12-18 Impact factor: 3.894
Authors: Sophie Lauzier; Elizabeth Maunsell; Mélanie Drolet; Douglas Coyle; Nicole Hébert-Croteau; Jacques Brisson; Benoît Mâsse; Belkacem Abdous; André Robidoux; Jean Robert Journal: J Natl Cancer Inst Date: 2008-02-26 Impact factor: 13.506
Authors: Mahasin S Mujahid; Nancy K Janz; Sarah T Hawley; Jennifer J Griggs; Ann S Hamilton; John Graff; Steven J Katz Journal: J Cancer Surviv Date: 2010-10-09 Impact factor: 4.442
Authors: Nancy A Borstelmann; Tamryn F Gray; Shari Gelber; Shoshana Rosenberg; Yue Zheng; Meghan Meyer; Kathryn J Ruddy; Lidia Schapira; Steven Come; Virginia Borges; Tamara Cadet; Peter Maramaldi; Ann H Partridge Journal: Support Care Cancer Date: 2022-01-28 Impact factor: 3.603
Authors: Elise Martin; Antonio Di Meglio; Gwenn Menvielle; Johanna Arvis; Aurélie Bourmaud; Stefan Michiels; Barbara Pistilli; Ines Vaz-Luis; Agnès Dumas Journal: Support Care Cancer Date: 2022-07-12 Impact factor: 3.359
Authors: Roni Nitecki; Shuangshuang Fu; Kirsten A Jorgensen; Lauren Gray; Carolyn Lefkowits; Benjamin D Smith; Larissa A Meyer; Alexander Melamed; Sharon H Giordano; Pedro T Ramirez; Jose Alejandro Rauh-Hain Journal: Int J Gynecol Cancer Date: 2021-11-16 Impact factor: 4.661
Authors: Catherine Benedict; Jason Wang; Marina Reppucci; Charles L Schleien; Jonathan D Fish Journal: Transl Behav Med Date: 2021-02-11 Impact factor: 3.046
Authors: Clare Meernik; Dale P Sandler; Lucy A Peipins; M Elizabeth Hodgson; Victoria S Blinder; Stephanie B Wheeler; Hazel B Nichols Journal: JNCI Cancer Spectr Date: 2021-03-17